Omeros Corp (OMER)
3.92
0.00 (0.00%)
USD |
NASDAQ |
Sep 27, 16:00
3.92
0.00 (0.00%)
After-Hours: 20:00
Omeros SG&A Expense (TTM): 53.37M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 53.37M |
March 31, 2024 | 50.82M |
December 31, 2023 | 49.66M |
September 30, 2023 | 52.37M |
June 30, 2023 | 48.15M |
March 31, 2023 | 50.81M |
December 31, 2022 | 50.67M |
September 30, 2022 | 49.64M |
June 30, 2022 | 51.45M |
March 31, 2022 | 53.02M |
December 31, 2021 | 54.84M |
September 30, 2021 | 36.79M |
June 30, 2021 | 42.61M |
March 31, 2021 | 44.06M |
December 31, 2020 | 49.31M |
September 30, 2020 | 46.01M |
June 30, 2020 | 43.12M |
March 31, 2020 | 43.12M |
December 31, 2019 | 39.71M |
September 30, 2019 | 63.38M |
June 30, 2019 | 59.60M |
March 31, 2019 | 55.42M |
December 31, 2018 | 51.72M |
September 30, 2018 | 48.86M |
June 30, 2018 | 47.46M |
Date | Value |
---|---|
March 31, 2018 | 50.51M |
December 31, 2017 | 52.04M |
September 30, 2017 | 51.86M |
June 30, 2017 | 50.56M |
March 31, 2017 | 45.14M |
December 31, 2016 | 43.78M |
September 30, 2016 | 41.34M |
June 30, 2016 | 39.93M |
March 31, 2016 | 37.45M |
December 31, 2015 | 35.33M |
September 30, 2015 | 34.33M |
June 30, 2015 | 30.86M |
March 31, 2015 | 27.82M |
December 31, 2014 | 22.60M |
September 30, 2014 | 18.08M |
June 30, 2014 | 16.72M |
March 31, 2014 | 15.60M |
December 31, 2013 | 15.82M |
September 30, 2013 | 15.65M |
June 30, 2013 | 14.18M |
March 31, 2013 | 12.65M |
December 31, 2012 | 10.98M |
September 30, 2012 | 9.365M |
June 30, 2012 | 8.459M |
March 31, 2012 | 8.274M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
36.79M
Minimum
Sep 2021
63.38M
Maximum
Sep 2019
48.65M
Average
49.65M
Median
SG&A Expense (TTM) Benchmarks
Harrow Inc | 107.88M |
Amphastar Pharmaceuticals Inc | 88.15M |
PetIQ Inc | 208.04M |
Alector Inc | 57.09M |
Outset Medical Inc | 132.37M |